Shares of Moderna Inc. MRNA slipped 3.43% to $65.69 Friday, on what proved to be an all-around mixed trading session for the ...

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have ...

Warning: COVID Vaccines Linked to Cancer Risks, Experts Say** In a shocking revelation that could alter the narrative surrounding COVID-19 vaccinations, a prominent molecular vi ...

We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Epidemiologists and a federal health agency have criticized new COVID-19 guidance from Florida Surgeon General Joseph Ladapo ...

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a handful of its pipeline programs and terminate a few others. Now, management is ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...